How many institutional investors hold ASBP?

1 tracked institutional investor disclosed a position in ASBP (ASPIRE BIOPHARMA HLDGS INC) in their most recent 13F filing.

Who is the largest institutional holder of ASBP?

Izzy Englander, Millennium Management, holds the largest disclosed position in ASBP, valued at $18,618.

Where does this ASBP ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

ASBP — ASPIRE BIOPHARMA HLDGS INC

Name: ASPIRE BIOPHARMA HLDGS INC (ASBP) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying ASBP?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence

Institutional Conviction

Net accumulation · 1 buying vs 0 selling last quarter

Macro Tailwind

Macro conditions are mixed for this sector

Why? — Evidence & Confidence ▾

Of 1 tracked investors who changed their ASBP position last quarter, 1 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Squeeze regime).

Supporting evidence

+1 tracked investor added or increased positions last quarter (Izzy Englander)
+1 tracked investors reported holding ASBP at their latest filing
+Macro Health is 55/100 in a Squeeze regime — historically acceptable for this sectorsource

Contradicting evidence — always shown

−13F data is disclosed up to 45 days after quarter end — positions may have changed since

Know the limits

· 13F disclosure lag (up to 45 days)
· Tracked investors are a sample, not the whole market
· Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/20/2026.

About ASPIRE BIOPHARMA HLDGS INC (ASBP)

ASPIRE BIOPHARMA HLDGS INC (ASBP) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $18,618. Across recent filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 3 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in ASBP

/100

Mixed Activity

Added / Increased4

Reduced0

Exited3

BearishBullish

Crowded Trade Score™

How many top investors track ASBP

/100

Undiscovered

1investor

Only 1 tracked investor report this position.

UndiscoveredCrowded

151015+

ASBP Ownership Composition

How ASPIRE BIOPHARMA HLDGS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Multi-Strategy / Quant

100% of tracked value

Institutions

tracked investors

Total Reported

$5.5K

combined 13F value

Multi-Strategy / Quant100.0%

Multi-Strategy / Quant(1)

100.0%

Tracked investors currently reporting ASBP

2 tracked investors have since exited this position — listed separately below.

Investor	Firm	Shares	Market value	% of portfolio	As of
Izzy Englander	Millennium Management	275K	$5.5K	0.00%	Jun 30, 2026

Izzy EnglanderJun 30, 2026
Millennium Management
Shares
275K
Value
$5.5K
% Portfolio
0.00%

Previously held ASBP

These investors reported ASBP in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

Investor	Firm	Last reported shares	Value then	Last held
Ken Griffin	Citadel Advisors	26.9K	$15.7K	Mar 31, 2025
Steve Cohen	Point72 Asset Management	14.2K	$1.9K	Dec 31, 2025

Recent activity

Investor	Action	Δ %	Current value	Filing date
Izzy Englander	New	—	$18.6K	May 15, 2025
Izzy Englander	Unchanged	0.00%	$12.3K	Aug 14, 2025
Izzy Englander	Sold	-100.00%	$0	Feb 17, 2026
Izzy Englander	New	—	$5.5K	Aug 14, 2026
Ken Griffin	New	—	$15.7K	May 15, 2025
Ken Griffin	Sold	-100.00%	$0	Aug 14, 2025
Steve Cohen	New	—	$1.9K	Feb 17, 2026
Steve Cohen	Sold	-100.00%	$0	May 15, 2026

Izzy Englander
New
$18.6KMay 15, 2025
Izzy Englander
Unchanged
$12.3K(0.00%)Aug 14, 2025
Izzy Englander
Sold
$0(-100.00%)Feb 17, 2026
Izzy Englander
New
$5.5KAug 14, 2026
Ken Griffin
New
$15.7KMay 15, 2025
Ken Griffin
Sold
$0(-100.00%)Aug 14, 2025
Steve Cohen
New
$1.9KFeb 17, 2026
Steve Cohen
Sold
$0(-100.00%)May 15, 2026

Frequently asked questions

How many institutional investors hold ASBP?: 1 tracked institutional investor disclosed a position in ASBP (ASPIRE BIOPHARMA HLDGS INC) in their most recent 13F filing.
Who is the largest institutional holder of ASBP?: Izzy Englander, Millennium Management, holds the largest disclosed position in ASBP, valued at $18,618.
Did institutional ownership of ASBP increase or decrease?: Across recent 13F filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 3 fully exited ASBP.
Where does this ASBP ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.